1,756
Participants
Start Date
January 31, 2013
Primary Completion Date
December 16, 2019
Study Completion Date
December 16, 2019
Avelumab
Participants received intravenous infusion of Avelumab in dose escalation and expansion cohorts until confirmed progression, unacceptable toxicity, or any reason for withdrawal from the trial or IMP occurs.
National Taiwan University Hospital, Taipei
National Cheng Kung University Hospital, Tainan City
GZA Ziekenhuizen - Campus Sint-Augustinus, Wilrijk
Columbia University College of Phys & Surgeons, New York
Montefiore Medical Center PRIME, The Bronx
Seoul National University Bundang Hospital, Seongnam-si
Penn State Univ. Milton S. Hershey Medical Center - MSHMC Cardiology, Hershey
Georgetown University Medical Center- Research Parent, Washington D.C.
RCCA MD LLC - Bethesda, Bethesda
Maryland Oncology Hematology, P.A., Rockville
National Cancer Institute, Bethesda
University of North Carolina at Chapel Hill, Chapel Hill
Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center, Huntersville
Medical University of South Carolina, Charleston
Northwest Georgia Oncology Centers PC, Marietta
Peachtree Hematology-Oncology Consultants, PC, Atlanta
Northeast Georgia Cancer Care, LLC, Athens
Augusta University - formerly Georgia Regents University, Augusta
University of Miami, Miami
Holy Cross Hospital, Fort Lauderdale
Florida Cancer Specialists, Sarasota
Hematology - Oncology Associates of Treasure Coast - Hematology-Oncology Associates of Treasure Coast, Port Saint Lucie
SCRI - Tennessee Oncology, Nashville
Baptist Cancer Center, Memphis
The West Clinic, Germantown
Mid Ohio Oncology Hematology, DBA The Mark H. Zangmeister Center - d/b/a The Mark H. Zangmeister Center, Columbus
University Hospitals Case Medical Center - Case Comprehensive Cancer Center, Cleveland
Horizon Oncology Research, INC, Lafayette
Karmanos Cancer Institute, Detroit
Henry Ford Medical Center, Detroit
Michigan State University, Lansing
ICO - Site Paul Papin - service d'oncologie medicale, Angers
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz - I. Medizinische Klinik Gastroenterologie u Hepato., Mainz
Virginia Piper Cancer Institute, Minneapolis
University of Chicago Medical Center, Chicago
Washington University in St. Louis, St Louis
Kansas City Research Institute, LLC - Phase I Unit, Kansas City
Centre Paul Strauss - Service de Médecine Oncologique, Strasbourg
Centre Léon Bérard, Lyon
Highlands Oncology Group, Rogers
Oklahoma University Medical Center, Oklahoma City
Texas Oncology, P.A, Dallas
Texas Oncology, P.A. - Tyler, Tyler
Oncology Consultants, P.A., Houston
Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH - Innere Medizin II Haematologie / Onkologie, Villingen-Schwenningen
Pinnacle Oncology Hematology, Scottsdale
Cancer Treatment Centers of America - Western Regional Medical Center, Goodyear
San Juan Oncology Associates, Farmington
The Angeles Clinic and Research Institute - West LA, Los Angeles
Cedars-Sinai Medical Center - Oncology, Los Angeles
Healing Hands Oncology and Medical Care, Inglewood
California Cancer Associates for Research & Excellence, Inc, Encinitas
Scripps Health dba Scripps Clinical Research Services, La Jolla
Sharp Memorial Hospital, San Diego
Pacific Cancer Medical Center, Inc., Anaheim
University of California Davis Health System, Sacramento
Scottsdale Healthcare Corporation, Scottsdale
The Johns Hopkins Hospital, Baltimore
UC Health Clinical Trials Office, Cincinnati
OSU - James Comprehensive Cancer Center - Division of Hematology, Columbus
Rhode Island Hospital, Providence
Northwest Medical Specialties, PLLC, Lakewood
Nemocnice Rudolfa a Stefanie Benesov, a.s., Benešov
Centre Antoine Lacassagne, Nice
Centrum Onkologii-Instytut im. M. Sklodowskiej Curie - Dept of Digestive System Oncology, Warsaw
Korea University Anam Hospital, Seoul
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University, Seoul
Asan Medical Center, Seoul
Gangnam Severance Hospital, Yonsei University Health System, Seoul
Samsung Medical Center, Seoul
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul
Sarah Cannon Research Institute UK, London
Derriford Hospital - Dept of Oncology Clinical Trials, Plymouth
Merck KGaA, Darmstadt, Germany
INDUSTRY
EMD Serono Research & Development Institute, Inc.
INDUSTRY